Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-27T14:45:19.124Z Has data issue: false hasContentIssue false

Alpha-Mannosidosis: A Novel Cause of Bilateral Thalami and Dentate Nuclei Hyperintensity

Published online by Cambridge University Press:  06 September 2021

Maria J Malaquias*
Affiliation:
Neurology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal
Eduarda Pinto
Affiliation:
Neurorradiology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal
Jorge Oliveira
Affiliation:
Center for Predictive and Preventive Genetics (CGPP), Institute for Molecular and Cell Biology (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal
João P Freixo
Affiliation:
Center for Predictive and Preventive Genetics (CGPP), Institute for Molecular and Cell Biology (IBMC), Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto, Portugal
Carla Caseiro
Affiliation:
Unidade de Bioquímica Genética, Centro de Genética Médica Doutor Jacinto Magalhães, Centro Hospitalar Universitário do Porto, Porto, Portugal
Marina Magalhães
Affiliation:
Neurology Department, Centro Hospitalar Universitário do Porto, Porto, Portugal Neurology Department, Hospital Padre Américo, Centro Hospitalar do Tâmega e Sousa, Penafiel, Porto, Portugal
*
Correspondence to: Maria J. Malaquias, Neurology Department, Centro Hospitalar Universitário do Porto, Largo do Prof. Abel Salazar, Porto 4099-001, Portugal. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Type
Neuroimaging Highlight
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Alpha-mannosidosis is a rare autosomal recessive lysosomal storage disorder caused by mutations in the MAN2B1 gene. Reference Riise Stensland, Frantzen and Kuokkanen1 To date, a total of 154 variants have been identified in 191 patients worldwide. Reference Riise Stensland, Frantzen and Kuokkanen1 Symptoms usually begin in childhood, but milder forms may present only in adulthood. The most frequent systemic findings include skeletal abnormalities (81%), facial dysmorphia (70%), deafness (67%), immunodeficiency (recurrent respiratory tract infections; 53%), and organomegaly (namely, hepatosplenomegaly; 41%). Reference Zielonka, Garbade, Kölker, Hoffmann and Ries2 Nervous system involvement not only includes intellectual disability (>90%) but also psychomotor developmental regression, behavioral alterations and ataxia. Reference Zielonka, Garbade, Kölker, Hoffmann and Ries2 Brain magnetic resonance imaging (MRI) data is limited, with leukodystrophy and cerebellar atrophy representing the most frequently reported abnormalities. Reference Majovska, Nestrasil and Paulson3 Clinical-imaging descriptions are relevant to prompt recognition of this potentially treatable entity.

Herein is presented the case of a 49-year-old female patient born from healthy consanguineous parents. Birth and perinatal periods were unremarkable and motor and language acquisitions followed normal milestones. At the age of 7, psychomotor regression was noticed after a normal first year at primary school, as well as gait impairment and speech and learning difficulties. Around the same period, hearing loss was also perceived. At the age of 14, the patient presented bilateral tonic−clonic seizures. In subsequent years, the clinical picture was dominated by intellectual disability and the girl was never capable of attending school or working. At the age of 42, she was referred to our Neurology Department for the first time, due to cognitive deterioration, aggressiveness, and frequent falls. Medical history included hepatosplenomegaly, metrorrhagia, and early menopause. Bone abnormalities and past recurrent infections were denied. Neurological examination revealed cognitive delay, poor spontaneous speech, axial, and appendicular choreo-dystonic movements, axial instability, and ataxic gait. Facial dysmorphia was also notorious, comprising low set ears, prognathism, and high forehead. Brain MRI showed symmetrical T2-weighted images hyperintensity of superior aspects of both thalami (Figure 1A, B − arrows) and dentate nuclei (DN) of cerebellum (Figure 1C, D − arrowheads). Periventricular white matter hyperintensity on T2-FLAIR sequence was mild (Figure 1E, F) and no cerebellar atrophy was shown. During the 7 years of follow-up, the patient presented progressive cognitive deterioration, as well as motor and behavioral fluctuations. In 2020, clinical exome analysis identified a novel homozygous variant in MAN2B1 (NM_000528.4:c.1061C>T, p. Ser354Phe), initially classified as having uncertain clinical significance. Biochemical studies subsequently established a causal association by showing reduced alpha-mannosidase enzymatic activity in total peripheral blood leukocytes (1 nmol/h/mg protein; reference value 77−413) and abnormal urinary levels of mannose-rich oligosaccharides. In view of these findings, the new MAN2B1 variant was reclassified as likely pathogenic.

This study reports a childhood-onset case evaluated in adulthood of alpha-mannosidosis exhibiting rare neurological features (epilepsy and choreo-dystonic movements) and a novel MAN2B1 variant. Additionally, thalami and DN hyperintensity here described have not been previously reported, including in one series of 13 patients. Reference Zielonka, Garbade, Kölker, Hoffmann and Ries2 Previous brain MRI descriptions of alpha-mannosidosis comprised cerebellar and cortical atrophies, leukodystrophy, basal ganglia and thalami T2 hypointensity, corpus callosum thinning, Virchow−Robin spaces and widened perioptic cerebrospinal fluid spaces. Reference Majovska, Nestrasil and Paulson3Reference Zoons, de Koning, Abeling and Tijssen5 In recent quantitative studies, Majovska et al. did not confirm basal ganglia and thalami T2 hypointensity, suggesting that T2 hypointensity seen in these locations is due to adjacent white matter T2 hyperintensity and not to gray matter iron deposition, as formerly believed. Reference Majovska, Nestrasil and Paulson3,Reference Zoons, de Koning, Abeling and Tijssen5 The range of differential diagnoses of thalami and DN hyperintensity in neuropediatric genetic/metabolic disorders is narrow and includes cerebrotendinous xanthomatosis, Canavan disease, L2-hydroxyglutaric, and type 1 glutaric acidurias, Alexander´s disease, Leigh syndrome, and Wilson disease. Reference Van Cauter, Severino and Ammendola6Reference Hegde, Mohan, Lath and Lim8 We additionally propose that alpha-mannosidosis, traditionally regarded as a white matter disease, should be considered in the approach to central gray matter (thalami and DN) hyperintensity.

Figure 1: T2-weighted images performed at 49 years of age, showing symmetrical hyperintensity of superior aspects of both thalami (A, B – arrows) and dentate nuclei of cerebellum (C, D – arrowheads). Periventricular white matter hyperintensity on T2-FLAIR sequence was mild (E, F).

Disclosure

The authors report no disclosures relevant to the manuscript.

Statement of Authorship

  1. A. Research project conception and execution,

  2. B. Manuscript preparation,

  3. C. Writing of the first,

  4. D. Draft, review and critique.

  • MJM: A, B, C, D

  • EP: A, B, D

  • JO: A, B, D

  • JPF: A, B, D

  • CC: A, B, D

  • MM: A, B, C, D

References

Riise Stensland, HM, Frantzen, G, Kuokkanen, E, et al. A relational database for MAN2B1 allelic variants that compiles genotypes, clinical phenotypes, and biochemical and structural data of mutant MAN2B1 in α-mannosidosis. Hum Mutat. 2015;36:581–86. DOI 10.1002/humu.22787.CrossRefGoogle ScholarPubMed
Zielonka, M, Garbade, SF, Kölker, S, Hoffmann, GF, Ries, M. Ultra-orphan lysosomal storage diseases: a cross-sectional quantitative analysis of the natural history of alpha-mannosidosis. J Inherit Metab Dis. 2019;42:975–83. DOI 10.1002/jimd.12138.CrossRefGoogle ScholarPubMed
Majovska, J, Nestrasil, I, Paulson, A, et al. White matter alteration and cerebellar atrophy are hallmarks of brain MRI in alpha-mannosidosis. Mol Genet Metab. 2021;132:189–97. DOI 10.1016/j.ymgme.2020.11.008.CrossRefGoogle ScholarPubMed
Patlas, M, Shapira, MY, Nagler, A, Sheffer, R, Gomori, JM. MRI of mannosidosis. Neuroradiology. 2001;43:941–43. DOI 10.1007/s002340100607.CrossRefGoogle ScholarPubMed
Zoons, E, de Koning, TJ, Abeling, NG, Tijssen, MA. Neurodegeneration with brain iron accumulation on MRI: an adult case of α-mannosidosis. JIMD Rep. 2012;4:99102. DOI 10.1007/8904_2011_78.CrossRefGoogle ScholarPubMed
Van Cauter, S, Severino, M, Ammendola, R, et al. Bilateral lesions of the basal ganglia and thalami (central grey matter)-pictorial review. Neuroradiology. 2020;62:1565–605. DOI 10.1007/s00234-020-02511-y.CrossRefGoogle ScholarPubMed
Khadilkar, S, Jaggi, S, Patel, B, Yadav, R, Hanagandi, P, Faria do Amaral, LL. A practical approach to diseases affecting dentate nuclei. Clin Radiol. 2016;71:107–19. DOI 10.1016/j.crad.2015.09.010.CrossRefGoogle ScholarPubMed
Hegde, AN, Mohan, S, Lath, N, Lim, CC. Differential diagnosis for bilateral abnormalities of the basal ganglia and thalamus. Radiographics. 2011;31:530. DOI 10.1148/rg.311105041.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1: T2-weighted images performed at 49 years of age, showing symmetrical hyperintensity of superior aspects of both thalami (A, B – arrows) and dentate nuclei of cerebellum (C, D – arrowheads). Periventricular white matter hyperintensity on T2-FLAIR sequence was mild (E, F).